ABCG2 and cancer: One of the most probable explanations for reduced drug efficacy in ABCB1- and ABCG2-overexpressing multidrug-resistant cancer cells is the reduced intracellular drug accumulation caused by ABCB1- and ABCG2-mediated drug efflux [34].